Therma Bright Inc. TBRIF
0.02 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.025 Day range 0.0255
0.022 52-week range 0.066
- YTD
- -21.43%
- 1 year
- -61.40%
- Market cap
- 1.35M
- EPS (ttm)
- -0.07
- YTD return
- -21.43%
- 1-year return
- -61.40%
- Volume
- 50.00K
- Avg volume
- 2.56K
- Open
- 0.0255
- Previous close
- 0.022
- Day's range
- 0.025 – 0.0255
- 52-week range
- 0.022 – 0.066
2Y -0.1940 (-89.81%)
News
Therma Bright Announces up to $420,000 Non-Brokered Private Placement 
Therma Bright Inc. Completes Debt Settlements 
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume 
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets 
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually 
Therma Bright Grants Stock Options 
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial 
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med 
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication. 
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
Your note
Sign in to keep a note on TBRIF — it syncs with the Stock Master app.